Printer Friendly

Browse BRCA mutations topic

Research subtopic


1-12 out of 12 article(s)
Title Author Type Date Words
The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study. Camara, Sara; Pereira, Daniela; Andre, Saudade; Mira, Beatriz; Vaz, Fatima; Oom, Rodrigo; Marques, J Report Jan 1, 2018 3710
Clinical Characteristics in Patients with Triple Negative Breast Cancer. Yeh, Janet; Chun, Jennifer; Schwartz, Shira; Wang, Annie; Kern, Elizabeth; Guth, Amber A.; Axelrod, Report Jan 1, 2017 3581
Study links mutations to breast cancer treatment resistance. Brief article Dec 1, 2013 272
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers. Vesprini, Danny; Narod, Steven A; Trachtenberg, John; Crook, Juanita; Jalali, Farid; Preiner, John; Case study Apr 1, 2011 3938
Basal-like breast carcinoma: a phenotypically distinct entity. Haupt, Bisong; Ro, Jae Y.; Schwartz, Mary R. Report Jan 1, 2010 3832
Managing the contralateral breast in a gene mutation carrier with breast cancer. Benson, John R. Report Mar 1, 2009 5595
The care of breast cancer predisposition gene mutation carriers. Gui, Gerald Editorial Mar 1, 2009 774
High-risk breast cancer predisposition genes. Gareth, D.; Evans, R.; Howell, Anthony Report Mar 1, 2009 4026
Serial screening combo may flag early ovarian ca. Wendling, Patrice Sep 1, 2007 608
Figure family structure into BRCA screening. Jancin, Bruce Brief article Feb 1, 2007 325
Salpingo-oophorectomy cuts cancer risk in BRCA2 carriers. Tanzola, Melinda Clinical report Sep 15, 2006 396
Salpingo-oophorectomy cuts female Ca risks: in particular, the procedure lowers the incidence of breast cancer in women with BRCA2 mutations. Tanzola, Melinda Aug 15, 2006 427

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters